Suchergebnisse - "Rizvi, Hira"

PubPharm (12)

1

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Alessi, J. | Wang, X. | Elkrief, A. | +32

2

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Thummalapalli, R. | Ricciuti, B. | Bandlamudi, C. | +25

3

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas : a cohort study

enthalten in: Journal for immunotherapy of cancer | 2023

von Elkrief, A. | Alessi, J. | Ricciuti, B. | +18

4

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

enthalten in: Cancer cell | 2023

von Pai, J. | Hellmann, M. | Sauter, J. | +30

CommentIn: Cancer Cell. 2023 Apr 10;41(4):653-655. - PMID 37001525

5

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer

enthalten in: Immunity | 2023

von Chow, A. | Uddin, F. | Liu, M. | +38

6

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Ricciuti, B. | Arbour, K. | Lin, J. | +30

CommentIn: J Thorac Oncol. 2022 Mar;17(3):351-352. - PMID 35216730

7

Beyond Steroids : Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Luo, J. | Beattie, J. | Fuentes, P. | +10

8

Immunotherapy-Mediated Thyroid Dysfunction : Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Luo, J. | Martucci, V. | Quandt, Z. | +18

9

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Mezquita, L. | Preeshagul, I. | Auclin, E. | +34

10

Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Arbour, K. | Rizvi, H. | Plodkowski, A. | +10